ABVX – Abivax ADR

ABVX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.38

Margin Of Safety %

Put/Call OI Ratio

0.43

EPS Next Q Diff

0.04

EPS Last/This Y

1.99

EPS This/Next Y

0.44

Price

131.02

Target Price

162.06

Analyst Recom

1.28

Performance Q

5.04

Upside

-188.2%

Beta

1.04

Ticker: ABVX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	ABVX	134.87	0.50	0.47	197262
2026-07-15	ABVX	136.84	0.51	0.28	200776
2026-07-16	ABVX	137.92	0.52	0.12	199405
2026-07-17	ABVX	136.73	0.52	0.88	202108
2026-07-20	ABVX	131.38	0.45	0.22	141827
2026-07-21	ABVX	134.24	0.45	0.39	145840
2026-07-22	ABVX	129.7	0.46	0.26	148473
2026-07-23	ABVX	131.06	0.46	0.15	151653
2026-07-24	ABVX	125.76	0.45	0.54	154407
2026-07-27	ABVX	127.94	0.44	0.23	147298
2026-07-28	ABVX	124.16	0.44	0.61	149920
2026-07-29	ABVX	118.99	0.44	0.23	152720
2026-07-30	ABVX	124.23	0.44	0.56	154642
2026-07-31	ABVX	124.76	0.44	0.40	157404
2026-08-03	ABVX	124.76	0.44	0.25	149668
2026-08-04	ABVX	125.2	0.44	0.16	152291
2026-08-05	ABVX	125.38	0.44	0.14	153395
2026-08-06	ABVX	129.92	0.43	0.12	156776
2026-08-07	ABVX	131.01	0.43	0.74	159045
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	ABVX	134.84	-1.4	-	-3.64
2026-07-15	ABVX	136.85	-1.4	-	-3.64
2026-07-16	ABVX	137.79	-1.4	-	-3.64
2026-07-17	ABVX	136.73	-1.4	-	-3.64
2026-07-20	ABVX	131.33	-1.4	-	-3.64
2026-07-21	ABVX	134.24	-1.4	-	-3.64
2026-07-22	ABVX	129.66	-1.4	-	-3.64
2026-07-23	ABVX	131.15	-1.4	-	-3.64
2026-07-24	ABVX	125.78	-1.4	-	-3.64
2026-07-27	ABVX	127.91	-1.3	-	-3.58
2026-07-28	ABVX	124.13	-1.3	-	-3.58
2026-07-29	ABVX	118.81	-1.3	-	-3.58
2026-07-30	ABVX	124.30	-1.3	-	-3.58
2026-07-31	ABVX	124.74	-1.3	-	-3.58
2026-08-03	ABVX	124.76	-1.3	-	-3.58
2026-08-04	ABVX	124.76	-1.3	-	-3.58
2026-08-05	ABVX	125.39	-1.3	-	-3.58
2026-08-06	ABVX	129.99	-1.3	-	-3.58
2026-08-07	ABVX	131.02	-1.3	-	-3.58
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	ABVX	0.00	-7.56	5.80
2026-07-15	ABVX	0.00	-7.56	5.80
2026-07-16	ABVX	0.00	-7.56	5.80
2026-07-17	ABVX	0.00	-7.56	5.79
2026-07-20	ABVX	0.00	-10.63	5.79
2026-07-21	ABVX	0.00	-10.63	5.79
2026-07-22	ABVX	0.00	-10.63	5.79
2026-07-23	ABVX	0.00	-10.63	5.79
2026-07-24	ABVX	0.00	-10.63	5.79
2026-07-27	ABVX	0.00	-10.31	5.38
2026-07-28	ABVX	0.00	-10.31	5.38
2026-07-29	ABVX	0.00	-10.31	5.38
2026-07-30	ABVX	0.00	-10.31	5.38
2026-07-31	ABVX	0.00	-10.31	5.38
2026-08-03	ABVX	0.00	-9.46	5.38
2026-08-04	ABVX	0.00	-9.46	5.38
2026-08-05	ABVX	0.00	-9.46	5.38
2026-08-06	ABVX	0.00	-9.46	5.38
2026-08-07	ABVX	0.00	-9.46	5.38
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.71

Avg. EPS Est. Current Quarter

-0.91

Avg. EPS Est. Next Quarter

-0.67

Insider Transactions

Institutional Transactions

-9.46

Beta

1.04

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

162.06

P/E

Forward P/E

PEG

P/S

P/B

20.97

P/Free Cash Flow

EPS

-5.25

Average EPS Est. Cur. Y

-3.58

EPS Next Y. (Est.)

-3.15

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.44

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-88.6

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.11

EBIT Estimation

◆ ABVX Healthcare

$130.93

📉

Swing / Pullback

Buy the dip on strong trends

WATCH

Trend

20/20

Pullback

12/25

Volume

11/15

Valuation

7/20

TP/AR

2/10

Options

7/10

RSI

55.9

Range 1M

55.6%

Sup Dist

3.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

12/25

Growth

18/30

Estimates

0/20

Inst/Vol

2/15

Options

7/10

EPS Yr

31.7%

EPS NY

7.2%

52W%

78.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +23.8% upside

Quality

2/30

Valuation

6/30

Growth

15/25

Stability

5/10

LT Trend

4/5

Upside

+23.8%

Quality

ABVX — P/E HistoricalBiotechnology

Abivax SA

Sector: Healthcare

Industry: Biotechnology

Employees: 80

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

ABVX

Latest News

—

Caricamento notizie per ABVX…

stock quote shares ABVX – Abivax ADR Stock Price stock today

news today ABVX – Abivax ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch ABVX – Abivax ADR yahoo finance google finance

stock history ABVX – Abivax ADR invest stock market

stock prices ABVX premarket after hours

ticker ABVX fair value insiders trading

SNY – Sanofi

SNY — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.31

Margin Of Safety %

Put/Call OI Ratio

0.95

EPS Next Q Diff

-0.13

EPS Last/This Y

1.24

EPS This/Next Y

0.39

Price

43.49

Target Price

50.6

Analyst Recom

2.29

Performance Q

Upside

N/A

Beta

0.31

Ticker: SNY

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	SNY	43.17	0.82	0.84	82927
2026-07-15	SNY	43.67	0.83	0.24	83271
2026-07-16	SNY	44.2	0.87	1.28	81971
2026-07-17	SNY	44.66	0.87	0.09	82238
2026-07-20	SNY	43.97	1.00	0.75	70061
2026-07-21	SNY	43.76	1.00	1.11	72256
2026-07-22	SNY	43.81	1.01	0.46	72877
2026-07-23	SNY	43.38	0.99	0.64	74762
2026-07-24	SNY	43.36	1.00	0.68	75955
2026-07-27	SNY	44.03	1.00	2.22	76591
2026-07-28	SNY	45.53	1.00	0.11	77134
2026-07-29	SNY	44.88	0.99	1.58	78039
2026-07-30	SNY	42.89	1.04	0.40	85719
2026-07-31	SNY	43.08	0.95	2.91	91413
2026-08-03	SNY	42.95	0.97	0.57	92815
2026-08-04	SNY	42.7	0.97	1.19	93101
2026-08-05	SNY	42.78	0.97	0.04	93408
2026-08-07	SNY	43.5	0.95	0.35	94726
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	SNY	43.16	25.3	3921.3	4.79
2026-07-15	SNY	43.67	25.3	4250.3	4.79
2026-07-16	SNY	44.18	25.3	4266.6	4.79
2026-07-17	SNY	44.64	25.3	4281.9	4.79
2026-07-20	SNY	43.97	25.3	4075.6	4.79
2026-07-21	SNY	43.75	25.3	4081.3	4.79
2026-07-22	SNY	43.80	25.3	4113.8	4.79
2026-07-23	SNY	43.37	25.3	4003.2	4.79
2026-07-24	SNY	43.36	25.3	4209.0	4.79
2026-07-27	SNY	44.01	25.3	4405.0	4.79
2026-07-28	SNY	45.52	25.3	4518.7	4.79
2026-07-29	SNY	44.89	25.3	4165.6	4.79
2026-07-30	SNY	42.93	25.3	3655.2	4.79
2026-07-31	SNY	43.08	-5.7	5721.9	4.79
2026-08-03	SNY	42.96	-5.7	4531.7	4.79
2026-08-04	SNY	42.96	-5.7	4531.7	4.79
2026-08-05	SNY	42.78	-8.9	4647.8	4.88
2026-08-06	SNY	42.90	-8.9	4651.2	4.88
2026-08-07	SNY	43.49	-8.9	4739.4	4.93
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	SNY	0	-2.21	0.28
2026-07-15	SNY	0	-2.21	0.28
2026-07-16	SNY	0	-2.21	0.28
2026-07-17	SNY	0	-2.21	0.28
2026-07-20	SNY	0	-2.19	0.28
2026-07-21	SNY	0	-2.19	0.28
2026-07-22	SNY	0	-2.19	0.28
2026-07-23	SNY	0	-2.19	0.28
2026-07-24	SNY	0	-2.19	0.28
2026-07-27	SNY	0	-1.20	0.31
2026-07-28	SNY	0	-1.20	0.31
2026-07-29	SNY	0	-1.20	0.31
2026-07-30	SNY	0	-1.20	0.31
2026-07-31	SNY	0	-1.20	0.31
2026-08-03	SNY	0	-1.25	0.31
2026-08-04	SNY	0	-1.25	0.31
2026-08-05	SNY	0	-1.25	0.31
2026-08-06	SNY	0	-1.25	0.31
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

1.21

Avg. EPS Est. Current Quarter

1.54

Avg. EPS Est. Next Quarter

1.08

Insider Transactions

Institutional Transactions

-1.25

Beta

0.31

Average Sales Estimate Current Quarter

13277

Average Sales Estimate Next Quarter

12441

Fair Value

49.9

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

27.7

Max Drawdown 5-Year %

-33.5

Target Price

50.6

P/E

22.09

Forward P/E

8.17

PEG

1.13

P/S

1.93

P/B

1.32

P/Free Cash Flow

8.54

EPS

1.94

Average EPS Est. Cur. Y

4.93

EPS Next Y. (Est.)

5.33

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.78

Relative Volume

1.23

Return on Equity vs Sector %

-21.6

Return on Equity vs Industry %

-31.8

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

-0.02

EBIT Estimation

4739.4

No data found for SNY

SNY — P/E HistoricalDrug Manufacturers - General

Sanofi

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 74846

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

SNY

Latest News

—

Caricamento notizie per SNY…

stock quote shares SNY – Sanofi Stock Price stock today

news today SNY – Sanofi stock forecast ,stock prediction 2023 2024 2025

marketwatch SNY – Sanofi yahoo finance google finance

stock history SNY – Sanofi invest stock market

stock prices SNY premarket after hours

ticker SNY fair value insiders trading

TTE – Total Energies SE

TTE — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.27

Margin Of Safety %

Put/Call OI Ratio

0.93

EPS Next Q Diff

-0.13

EPS Last/This Y

4.8

EPS This/Next Y

-1

Price

85.83

Target Price

97.5

Analyst Recom

1.82

Performance Q

Upside

N/A

Beta

0.16

Ticker: TTE

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	TTE	80.93	0.80	3.40	61908
2026-07-15	TTE	80.31	0.84	0.70	63655
2026-07-16	TTE	78.83	0.84	0.40	64069
2026-07-17	TTE	81.44	0.84	0.09	64162
2026-07-20	TTE	80.87	0.90	0.13	57339
2026-07-21	TTE	83.49	0.90	0.12	57644
2026-07-22	TTE	84.98	0.90	0.13	57685
2026-07-23	TTE	86.23	0.88	0.18	58339
2026-07-24	TTE	86.82	0.87	0.67	59087
2026-07-27	TTE	84.18	0.87	1.16	59299
2026-07-28	TTE	84.16	0.87	0.41	59432
2026-07-29	TTE	86.75	0.87	0.93	59537
2026-07-30	TTE	87.01	0.87	0.53	59670
2026-07-31	TTE	87.96	0.87	0.03	59677
2026-08-03	TTE	87.19	0.86	5.72	60395
2026-08-04	TTE	85.16	0.94	0.42	63240
2026-08-05	TTE	84.67	0.94	0.37	63291
2026-08-07	TTE	85.8	0.93	0.60	63491
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	TTE	80.97	-	7578.0	10.56
2026-07-15	TTE	80.30	-	6823.3	10.56
2026-07-16	TTE	78.82	-	6512.9	10.56
2026-07-17	TTE	81.44	-	7950.5	10.56
2026-07-20	TTE	80.89	-	6999.6	10.56
2026-07-21	TTE	83.48	-	7696.4	10.33
2026-07-22	TTE	84.95	-	7552.7	10.33
2026-07-23	TTE	86.21	-	7012.1	10.33
2026-07-24	TTE	86.79	-	7071.2	10.33
2026-07-27	TTE	84.18	-	2557.7	10.60
2026-07-28	TTE	84.18	-	2614.9	10.66
2026-07-29	TTE	86.73	-	3747.1	10.66
2026-07-30	TTE	87.04	-	1995.3	10.64
2026-07-31	TTE	87.91	-	3193.3	10.64
2026-08-03	TTE	87.20	-	2623.2	10.64
2026-08-04	TTE	87.20	-	2623.2	10.64
2026-08-05	TTE	84.68	-	3161.7	10.64
2026-08-06	TTE	86.22	-	3895.2	10.64
2026-08-07	TTE	85.83	-	3443.4	10.64
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	TTE	0.00	7.20	0.25
2026-07-15	TTE	0.00	7.20	0.25
2026-07-16	TTE	0.00	7.20	0.25
2026-07-17	TTE	0.00	7.20	0.25
2026-07-20	TTE	0.00	7.25	0.25
2026-07-21	TTE	0.00	7.25	0.25
2026-07-22	TTE	0.00	7.25	0.25
2026-07-23	TTE	0.00	7.25	0.25
2026-07-24	TTE	0.00	7.25	0.25
2026-07-27	TTE	0.00	-6.85	0.27
2026-07-28	TTE	0.00	-6.85	0.27
2026-07-29	TTE	0.00	-6.85	0.27
2026-07-30	TTE	0.00	-6.85	0.27
2026-07-31	TTE	0.00	-6.85	0.27
2026-08-03	TTE	0.00	-12.13	0.27
2026-08-04	TTE	0.00	-12.13	0.27
2026-08-05	TTE	0.00	-12.13	0.27
2026-08-06	TTE	0.00	-12.13	0.27
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

2.68

Avg. EPS Est. Current Quarter

2.87

Avg. EPS Est. Next Quarter

2.55

Insider Transactions

Institutional Transactions

-12.13

Beta

0.16

Average Sales Estimate Current Quarter

55809

Average Sales Estimate Next Quarter

52696

Fair Value

89.72

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

8.9

Max Drawdown 5-Year %

-26.4

Target Price

97.5

P/E

10.65

Forward P/E

9.13

PEG

0.9

P/S

0.98

P/B

1.49

P/Free Cash Flow

11.6

EPS

8.1

Average EPS Est. Cur. Y

10.64

EPS Next Y. (Est.)

9.64

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.08

Relative Volume

0.7

Return on Equity vs Sector %

2.7

Return on Equity vs Industry %

3.4

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

-0.78

EBIT Estimation

3443.4

No data found for TTE

TTE — P/E HistoricalOil & Gas Integrated

TotalEnergies SE

Sector: Energy

Industry: Oil & Gas Integrated

Employees: 94847

TotalEnergies SE, an integrated energy company, produces and markets oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables, and electricity in France, the United States, Europe, Brazil, India, and internationally. Its Exploration & Production segment engages in the activities of exploration and production of oil and natural gas, as well as carbon storage. The company's Integrated LNG segment is involved in the upstream and midstream LNG activities, as well as biogas and synthetic methane activities, as well as gas trading. Its Integrated Power segment engages in the generation, storage, electricity trading, and B2B-B2C distribution of gas and electricity. The company's Refining & Chemicals segment is involved in the industrial hub activities comprising the activities of refining, petrochemicals and specialty chemicals. This segment also includes the activities of oil supply, trading and marine shipping, as well as hydrogen activities. Its Marketing & Services segment engages in the marketing activities in the field of petroleum products as well as corresponding supply and logistics activities. The company was formerly known as TOTAL SE and changed its name to TotalEnergies SE in June 2021. TotalEnergies SE was incorporated in 1924 and is headquartered in Courbevoie, France.

TTE

Latest News

—

Caricamento notizie per TTE…

stock quote shares TTE – Total Energies SE Stock Price stock today

news today TTE – Total Energies SE stock forecast ,stock prediction 2023 2024 2025

marketwatch TTE – Total Energies SE yahoo finance google finance

stock history TTE – Total Energies SE invest stock market

stock prices TTE premarket after hours

ticker TTE fair value insiders trading

CSTM – Constellium SE

CSTM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.3

Margin Of Safety %

Put/Call OI Ratio

0.38

EPS Next Q Diff

-0.61

EPS Last/This Y

1.71

EPS This/Next Y

-1.25

Price

29.46

Target Price

37.4

Analyst Recom

1.4

Performance Q

Upside

362.5%

Beta

1.56

Ticker: CSTM

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	CSTM	29.16	0.45	0.59	31539
2026-07-15	CSTM	29.18	0.45	0.17	31586
2026-07-16	CSTM	28.54	0.43	0.26	31942
2026-07-17	CSTM	28.12	0.43	0.57	32083
2026-07-20	CSTM	27.79	0.44	0.10	28805
2026-07-21	CSTM	28.51	0.44	0.71	29020
2026-07-22	CSTM	29.32	0.43	0.14	29098
2026-07-23	CSTM	30	0.42	0.02	30011
2026-07-24	CSTM	29.04	0.41	0.04	30531
2026-07-27	CSTM	29.49	0.39	0.01	31165
2026-07-28	CSTM	29.05	0.38	0.15	31991
2026-07-29	CSTM	27.58	0.38	0.06	32145
2026-07-30	CSTM	28.57	0.37	0.40	33572
2026-07-31	CSTM	27.78	0.37	0.40	33601
2026-08-03	CSTM	28.43	0.37	2.25	34099
2026-08-04	CSTM	29.67	0.38	0.53	35340
2026-08-05	CSTM	29.65	0.38	0.08	35212
2026-08-06	CSTM	28.6	0.37	0.76	35496
2026-08-07	CSTM	29.46	0.38	0.08	35649
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	CSTM	29.15	876.2	-	3.06
2026-07-15	CSTM	29.15	876.2	-	3.06
2026-07-16	CSTM	28.54	876.2	-	3.06
2026-07-17	CSTM	28.08	876.2	-	3.06
2026-07-20	CSTM	27.79	876.2	-	3.06
2026-07-21	CSTM	28.50	876.2	-	3.06
2026-07-22	CSTM	29.33	876.2	-	3.06
2026-07-23	CSTM	29.98	876.2	-	3.06
2026-07-24	CSTM	29.06	876.2	-	3.06
2026-07-27	CSTM	29.52	876.2	-	3.06
2026-07-28	CSTM	29.07	876.2	-	3.06
2026-07-29	CSTM	27.59	876.2	-	3.06
2026-07-30	CSTM	28.59	876.2	-	3.06
2026-07-31	CSTM	27.76	876.2	-	3.06
2026-08-03	CSTM	28.44	34.2	-	3.66
2026-08-04	CSTM	28.44	34.2	-	3.66
2026-08-05	CSTM	29.65	34.2	-	3.66
2026-08-06	CSTM	28.59	34.2	-	3.66
2026-08-07	CSTM	29.46	34.2	-	3.66
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	CSTM	-3.32	0.92	4.62
2026-07-15	CSTM	-3.32	0.92	4.62
2026-07-16	CSTM	-3.32	0.92	4.62
2026-07-17	CSTM	-3.32	0.92	4.62
2026-07-20	CSTM	-3.29	1.10	4.63
2026-07-21	CSTM	-3.29	1.10	4.63
2026-07-22	CSTM	-3.29	1.10	4.63
2026-07-23	CSTM	-3.29	1.10	4.63
2026-07-24	CSTM	-3.29	1.10	4.63
2026-07-27	CSTM	-3.29	1.56	5.27
2026-07-28	CSTM	-3.29	1.56	5.27
2026-07-29	CSTM	-3.29	1.56	5.27
2026-07-30	CSTM	-3.29	1.56	5.27
2026-07-31	CSTM	-3.29	1.56	5.27
2026-08-03	CSTM	-3.30	1.15	5.30
2026-08-04	CSTM	-3.29	1.15	5.30
2026-08-06	CSTM	-3.29	1.15	5.30
2026-08-07	CSTM	-3.29	1.15	5.30
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

1.04

Avg. EPS Est. Current Quarter

0.64

Avg. EPS Est. Next Quarter

0.43

Insider Transactions

-3.29

Institutional Transactions

1.15

Beta

1.56

Average Sales Estimate Current Quarter

2334

Average Sales Estimate Next Quarter

2235

Fair Value

34.06

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

20.4

Max Drawdown 5-Year %

-66.3

Target Price

37.4

P/E

7.57

Forward P/E

10.92

PEG

0.34

P/S

0.42

P/B

3.2

P/Free Cash Flow

EPS

3.89

Average EPS Est. Cur. Y

3.66

EPS Next Y. (Est.)

2.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.69

Relative Volume

0.6

Return on Equity vs Sector %

27.1

Return on Equity vs Industry %

29.5

EPS 1 7Days Diff

0.6

EPS 1 30Days Diff

0.68

EBIT Estimation

◆ CSTM Basic Materials

$29.44

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

15/25

Volume

9/15

Valuation

17/20

TP/AR

4/10

Options

7/10

RSI

49.4

Range 1M

84.6%

Sup Dist

4.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

19/30

Estimates

7/20

Inst/Vol

3/15

Options

10/10

EPS Yr

205.8%

52W%

70%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +103.4% upside

Quality

16/30

Valuation

26/30

Growth

14/25

Stability

4/10

LT Trend

2/5

Upside

+103.4%

Quality

MoS

16%

CSTM — P/E HistoricalAluminum

Constellium SE

Sector: Basic Materials

Industry: Aluminum

Employees: 11500

Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the aerospace, packaging, automotive, commercial transportation, general industrial, and defense end-markets. It operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry. The Packaging & Automotive Rolled Products segment produces and develops rolled aluminum products, including canstock and closure stock for the beverage and food industry, as well as foil stock for the flexible packaging market. This segment also supplies automotive body sheets, heat exchangers, and battery foil products for the automotive market. The Aerospace & Transportation segment provides aluminum products including plate, sheet, and extrusions to aerospace, space, commercial transportation, general industrial, and defense sectors. The Automotive Structures & Industry segment offers structural solutions for the automotive industry including crash management systems, body structures, side impact beams, and battery enclosure components; soft and hard alloy extrusions for automotive, transportation, and general industrial applications; and profiles for rail and general industrial applications. This segment also provides downstream technology and services, which include pre-machining, surface treatment, research and development, and technical support services. It sells its products directly or through distributors in France, Germany, the Czech Republic, the United Kingdom, Switzerland, and the United States, as well as South Korea, Japan and China. The company was incorporated in 2010 and is headquartered in Paris, France.

CSTM

Latest News

—

Caricamento notizie per CSTM…

stock quote shares CSTM – Constellium SE Stock Price stock today

news today CSTM – Constellium SE stock forecast ,stock prediction 2023 2024 2025

marketwatch CSTM – Constellium SE yahoo finance google finance

stock history CSTM – Constellium SE invest stock market

stock prices CSTM premarket after hours

ticker CSTM fair value insiders trading

ABVX – Abivax ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABVX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

SNY – Sanofi

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SNY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y